Overview

Pragmatic Trial of Obsessive-compulsive Disorder

Status:
Recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
This study includes a sequenced clinical trial in order to assess the efficacy of several switching or augment strategies when initial treatment is ineffective,and to provide strong evidence for clinical practice and international guidelines for Obsessive-Compulsive Disorder treatments.
Phase:
Phase 2
Details
Lead Sponsor:
Shanghai Mental Health Center
Collaborators:
First Affiliated Hospital of Jinan University
General Hospital of Ningxia Medical University
Guizhou Provincial People's Hospital
Hangzhou Seventh People's Hospital
Henan Mental Hospital
Nanjing Medical University
Seventh People's Hospital of Hangzhou
Suzhou Psychiatric Hospital
The First Affiliated Hospital of Kunming Medical College
The First Affiliated Hospital of Nanchang University
The first specialized hospital of harbin
The Second Affiliated Hospital of Xinxiang Medical University
West China Hospital
Wuhan Mental Health Centre
Treatments:
Aripiprazole
Fluvoxamine
Memantine
Sertraline
Venlafaxine Hydrochloride